Exousia Bio, Inc.
LMMY· OTC
LMMYExousia Bio, Inc.
Filed Sep 1, 2023 · 10-K · 93 days after period end · 0001683168-23-006240
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$26.78K | -$937.00 |
| EPS Diluted | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Exousia Bio, Inc. · CIK 1939937 · Engraved from SEC EDGAR
ended May 31, 2023 · filed Sep 1, 2023 · 93 d after period end
